- Complications
- Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
-
Han Na Jang, Tae Jung Oh
-
Diabetes Metab J. 2023;47(6):743-756. Published online September 6, 2023
-
DOI: https://doi.org/10.4093/dmj.2023.0018
-
-
9,645
View
-
886
Download
-
16
Web of Science
-
13
Crossref
-
Abstract
PDFPubReader ePub
- Diabetic peripheral neuropathy (DPN) is one of the most prevalent chronic complications of diabetes. The lifetime prevalence of DPN is thought to be >50%, and 15%–25% of patients with diabetes experience neuropathic pain, referred to as “painful DPN.” Appropriate treatment of painful DPN is important because this pain contributes to a poor quality of life by causing sleep disturbance, anxiety, and depression. The basic principle for the management of painful DPN is to control hyperglycemia and other modifiable risk factors, but these may be insufficient for preventing or improving DPN. Because there is no promising diseasemodifying medication for DPN, the pain itself needs to be managed when treating painful DPN. Drugs for neuropathic pain, such as gabapentinoids, serotonin–norepinephrine reuptake inhibitors, tricyclic antidepressants, alpha-lipoic acid, sodium channel blockers, and topical capsaicin, are used for the management of painful DPN. The U.S. Food and Drug Administration (FDA) has approved pregabalin, duloxetine, tapentadol, and the 8% capsaicin patch as drugs for the treatment of painful DPN. Recently, spinal cord stimulation using electrical stimulation is approved by the FDA for the treatment for painful DPN. This review describes the currently available pharmacological and nonpharmacological treatments for painful DPN.
-
Citations
Citations to this article as recorded by
- Diabetic peripheral neuropathy and neuromodulation techniques: a systematic review of progress and prospects
Rahul Mittal, Keelin McKenna, Grant Keith, Evan McKenna, Joana R. N. Lemos, Jeenu Mittal, Khemraj Hirani Neural Regeneration Research.2025; 20(8): 2218. CrossRef - J-2156, a small molecule somatostatin type 4 receptor agonist, alleviated hindpaw hypersensitivity in the streptozotocin-induced rat model of painful diabetic neuropathy but with a 2-fold decrease in potency at an advanced stage in the model, mimicking mo
A. Kuo, M. Z. Imam, R. Li, L. Lin, A. Raboczyj, A. E. Bohmer, J. R. Nicholson, L. Corradini, M. T. Smith Frontiers in Pharmacology.2024;[Epub] CrossRef - The Chronic Wound–Related Pain Model
Kevin Woo Clinics in Geriatric Medicine.2024; 40(3): 501. CrossRef - Diabetic Neuropathy: A Guide to Pain Management
Emily X. Zhang, Cyrus Yazdi, Rahib K. Islam, Ahmed I. Anwar, Alana Alvares-Amado, Horace Townsend, Kaitlyn E. Allen, Elena Plakotaris, Jon D. Hirsch, Ross G. Rieger, Varsha Allampalli, Jamal Hasoon, Kazi N. Islam, Sahar Shekoohi, Alan D. Kaye, Christopher Current Pain and Headache Reports.2024; 28(10): 1067. CrossRef - Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach
Aysegul Atmaca, Aysegul Ketenci, Ibrahim Sahin, Ihsan Sukru Sengun, Ramazan Ilyas Oner, Hacer Erdem Tilki, Mine Adas, Hatice Soyleli, Tevfik Demir Frontiers in Endocrinology.2024;[Epub] CrossRef - Predicting the efficacy of rehabilitation in patients with type 2 diabetes and diabetic polyneuropathy
T.H. Bakaliuk, N.R. Makarchuk, H.O. Stelmakh, V.I. Pankiv, I.I. Kamyshna INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(3): 155. CrossRef - Xiaoke Bitong capsule alleviates inflammatory impairment via inhibition of the TNF signaling pathway to against diabetic peripheral neuropathy
Lulu Tian, Meiqi Yang, Shanjie Tu, Kaixin Chang, Huanyu Jiang, Yuwei Jiang, Lu Ding, Zhiwei Weng, Yueqiang Wang, Xiaolong Tan, Chunxiao Zong, Buyang Chen, Xiaobing Dou, Xiuge Wang, Xuchen Qi Phytomedicine.2024; 132: 155867. CrossRef - Exploring the Efficacy of Alpha-Lipoic Acid in Comorbid Osteoarthritis and Type 2 Diabetes Mellitus
Iryna Halabitska, Valentyn Oksenych, Oleksandr Kamyshnyi Nutrients.2024; 16(19): 3349. CrossRef - Research Progress of Coenzyme Q in Diabetes Mellitus and Its Common Complications
Jingdong Xia, Xiudan Li, Chunying Bai, Xuchen Han Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3629. CrossRef - Negative allosteric modulator of Group Ⅰ mGluRs: Recent advances and therapeutic perspective for neuropathic pain
Jia-Ling Li, Chun-Hao Zhu, Miao-Miao Tian, Yue Liu, Lin Ma, Li-Jun Tao, Ping Zheng, Jian-Qiang Yu, Ning Liu Neuroscience.2024; 560: 406. CrossRef - A Missing Puzzle in Preclinical Studies—Are CCR2, CCR5, and Their Ligands’ Roles Similar in Obesity-Induced Hypersensitivity and Diabetic Neuropathy?—Evidence from Rodent Models and Clinical Studies
Aleksandra Bober, Joanna Mika, Anna Piotrowska International Journal of Molecular Sciences.2024; 25(20): 11323. CrossRef - Bibliometric and visualized analysis of 2014–2024 publications on therapy for diabetic peripheral neuropathy
Baitian Fu, Ning Luo, Yichen Zeng, Yutian Chen, Low Je Wie, Jianqiao Fang Frontiers in Neuroscience.2024;[Epub] CrossRef - The neuroprotective effects of progesterone against peripheral neuropathy: a systematic review of non-clinical studies
Hamed Haghi-Aminjan, Mahsa Kouhestani, Asieh Hosseini Metabolic Brain Disease.2024;[Epub] CrossRef
- Complications
- Prevalence of Diabetic Retinopathy in Undiagnosed Diabetic Patients: A Nationwide Population-Based Study
-
Han Na Jang, Min Kyong Moon, Bo Kyung Koo
-
Diabetes Metab J. 2022;46(4):620-629. Published online February 23, 2022
-
DOI: https://doi.org/10.4093/dmj.2021.0099
-
-
5,343
View
-
232
Download
-
4
Web of Science
-
5
Crossref
-
Abstract
PDFSupplementary MaterialPubReader ePub
- Background
We investigated the prevalence of diabetic retinopathy (DR) in patients with undiagnosed diabetes through a nationwide survey, compared to those with known diabetes.
Methods Among the participants of the Korean National Health and Nutrition Examination Surveys (KNHANES) from 2017 to 2018, individuals aged ≥40 years with diabetes and fundus exam results were enrolled. Sampling weights were applied to represent the entire Korean population. Newly detected diabetes patients through KNHANES were classified under “undiagnosed diabetes.”
Results Among a total of 9,108 participants aged ≥40 years, 951 were selected for analysis. Of them, 31.3% (standard error, ±2.0%) were classified under “undiagnosed diabetes.” The prevalence of DR in patients with known and undiagnosed diabetes was 24.5%±2.0% and 10.7%±2.2%, respectively (P<0.001). The DR prevalence increased with rising glycosylated hemoglobin (HbA1c) levels in patients with known and undiagnosed diabetes (P for trend=0.001 in both). Among those with undiagnosed diabetes, the prevalence of DR was 6.9%±2.1%, 8.0%±3.4%, 5.6%±5.7%, 16.7%±9.4%, and 42.6%±14.8% for HbA1c levels of <7.0%, 7.0%–7.9%, 8.0%–8.9%, 9.0%–9.9%, and ≥10.0% respectively. There was no difference in the prevalence of hypertension, dyslipidemia, hypertriglyceridemia, or obesity according to the presence or absence of DR.
Conclusion About one-third of patients with diabetes were unaware of their diabetes, and 10% of them have already developed DR. Considering increasing the prevalence of DR according to HbA1c level was found in patients with undiagnosed diabetes like those with known diabetes, screening and early detection of diabetes and DR are important.
-
Citations
Citations to this article as recorded by
- Risk factors of peripheral occlusive arterial disease in patients with diabetic retinopathy due to type 2 diabetes
Milos Maksimovic Srpski arhiv za celokupno lekarstvo.2024; 152(1-2): 50. CrossRef - Gene Expression Analysis in T2DM and Its Associated Microvascular Diabetic Complications: Focus on Risk Factor and RAAS Pathway
Laxmipriya Jena, Prabhsimran Kaur, Tashvinder Singh, Kangan Sharma, Sushil Kotru, Anjana Munshi Molecular Neurobiology.2024; 61(11): 8656. CrossRef - Trends and Barriers in Diabetic Retinopathy Screening: Korea National Health and Nutritional Examination Survey 2016–2021
Min Seok Kim, Sang Jun Park, Kwangsic Joo, Se Joon Woo Journal of Korean Medical Science.2024;[Epub] CrossRef - Novel Asian-Specific Visceral Adiposity Indices Are Associated with Chronic Kidney Disease in Korean Adults
Jonghwa Jin, Hyein Woo, Youngeun Jang, Won-Ki Lee, Jung-Guk Kim, In-Kyu Lee, Keun-Gyu Park, Yeon-Kyung Choi Diabetes & Metabolism Journal.2023; 47(3): 426. CrossRef - Prevalence of osteosarcopenic obesity and related factors among Iranian older people: Bushehr Elderly Health (BEH) program
Mozhgan Ahmadinezhad, Mohammad Ali Mansournia, Noushin Fahimfar, Gita Shafiee, Iraj Nabipour, Mahnaz Sanjari, Kazem Khalagi, Mohammad Javad Mansourzadeh, Bagher Larijani, Afshin Ostovar Archives of Osteoporosis.2023;[Epub] CrossRef
|